Published in Arq Bras Cardiol on November 01, 2002
Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease. J Am Coll Cardiol (2010) 2.38
Noncompaction cardiomyopathy: a current view. Arq Bras Cardiol (2011) 1.65
[Brazilian Guidelines for Valve Disease - SBC 2011 / I Guideline Inter-American Valve Disease - 2011 SIAC]. Arq Bras Cardiol (2011) 1.64
The role of echocardiography in diagnosis and management of isolated meningococcal pericarditis. Echocardiography (2007) 1.51
Progesterone abolishes estrogen and/or atorvastatin endothelium dependent vasodilatory effects. Atherosclerosis (2004) 1.50
Ten-year clinical laboratory follow-up after application of a symptom-based therapeutic strategy to patients with severe chronic aortic regurgitation of predominant rheumatic etiology. J Am Coll Cardiol (2003) 1.47
Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas' disease: a marker of disease severity. J Am Coll Cardiol (2005) 1.43
Combination of amlodipine and enalapril in hypertensive patients with coronary disease. Arq Bras Cardiol (2009) 1.43
Echocardiographic findings in patients with suspected infective endocarditis. Arq Bras Cardiol (2004) 1.42
Comparison between percutaneous balloon valvuloplasty and open commissurotomy for mitral stenosis. A prospective and randomized study. Cardiology (2002) 1.40
Advanced cardiac life support training improves long-term survival from in-hospital cardiac arrest. Resuscitation (2007) 1.40
Immediate and late results of percutaneous mitral valve repair in patients with mitral stenosis. Arq Bras Cardiol (2010) 1.39
Left atrium reverse remodeling in patients with mitral valve stenosis after percutaneous valvuloplasty: a 2- and 3-dimensional echocardiographic study. Rev Esp Cardiol (Engl Ed) (2012) 1.39
Late gadolinium enhancement magnetic resonance imaging in the diagnosis and prognosis of endomyocardial fibrosis patients. Circ Cardiovasc Imaging (2011) 1.34
Effectiveness of the maze procedure using cooled-tip radiofrequency ablation in patients with permanent atrial fibrillation and rheumatic mitral valve disease. Circulation (2005) 1.34
Pregnancy in patients with heart disease: experience with 1,000 cases. Clin Cardiol (2003) 1.24
Time-related distribution, risk factors and prognostic influence of embolism in patients with left-sided infective endocarditis. Int J Cardiol (2005) 1.22
Dysautonomia due to reduced cholinergic neurotransmission causes cardiac remodeling and heart failure. Mol Cell Biol (2010) 1.12
Increased plasma levels of tumor necrosis factor-alpha in asymptomatic/"indeterminate" and Chagas disease cardiomyopathy patients. Mem Inst Oswaldo Cruz (2003) 1.11
Protein quality control disruption by PKCβII in heart failure; rescue by the selective PKCβII inhibitor, βIIV5-3. PLoS One (2012) 1.05
Heterozygosity for the S180L variant of MAL/TIRAP, a gene expressing an adaptor protein in the Toll-like receptor pathway, is associated with lower risk of developing chronic Chagas cardiomyopathy. J Infect Dis (2009) 1.02
Cardiac remodeling in patients with systemic sclerosis with no signs or symptoms of heart failure: an endomyocardial biopsy study. J Card Fail (2003) 1.02
Multivariate analysis of risk factors for hospital mortality in valvular reoperations for prosthetic valve dysfunction. Eur J Cardiothorac Surg (2002) 1.01
The reduction in hospital stay and costs in the care of patients with congenital heart diseases undergoing fast-track cardiac surgery. Arq Bras Cardiol (2004) 1.01
Effects of epinephrine in local dental anesthesia in patients with coronary artery disease. Arq Bras Cardiol (2007) 1.00
Myocardial chemokine expression and intensity of myocarditis in Chagas cardiomyopathy are controlled by polymorphisms in CXCL9 and CXCL10. PLoS Negl Trop Dis (2012) 1.00
Contrast-enhanced magnetic resonance imaging identifies focal regions of intramyocardial fibrosis in patients with severe aortic valve disease: Correlation with quantitative histopathology. Am Heart J (2008) 0.99
TNF blockade aggravates experimental chronic Chagas disease cardiomyopathy. Microbes Infect (2007) 0.97
Surgical treatment of atrial fibrillation through isolation of the left atrial posterior wall in patients with chronic rheumatic mitral valve disease. A randomized study with control group. Arq Bras Cardiol (2004) 0.96
Identification of multiple HLA-A*0201-restricted cruzipain and FL-160 CD8+ epitopes recognized by T cells from chronically Trypanosoma cruzi-infected patients. Microbes Infect (2005) 0.96
Effect of Losartan on left ventricular diastolic function in patients with nonobstructive hypertrophic cardiomyopathy. Am J Cardiol (2005) 0.96
The Syrian hamster as a model for the dilated cardiomyopathy of Chagas' disease: a quantitative echocardiographical and histopathological analysis. Microbes Infect (2003) 0.95
Mycobacterium chelonae valve endocarditis resulting from contaminated biological prostheses. J Infect (2010) 0.94
Influence of pregnancy after bioprosthetic valve replacement in young women: a prospective five-year study. J Heart Valve Dis (2002) 0.92
TNF gene polymorphisms are associated with reduced survival in severe Chagas' disease cardiomyopathy patients. Microbes Infect (2005) 0.92
Incremental value of perfusion over wall-motion abnormalities with the use of dobutamine-atropine stress myocardial contrast echocardiography and magnetic resonance imaging for detecting coronary artery disease. Echocardiography (2012) 0.92
Obstructive sleep apnea is common and independently associated with atrial fibrillation in patients with hypertrophic cardiomyopathy. Chest (2010) 0.91
Reference values from M-mode and Doppler echocardiography for normal Syrian hamsters. Eur J Echocardiogr (2005) 0.91
[Endocarditis due to Coxiella burnetii (Q fever): a rare or underdiagnosed disease? Case report]. Rev Soc Bras Med Trop (2008) 0.90
Influence of pregnancy on clinical course and fetal outcome of women with hypertrophic cardiomyopathy. Arq Bras Cardiol (2007) 0.90
Poll: Jehovah's witness patient. Arq Bras Cardiol (2010) 0.90
Clinical, electrocardiographic and echocardiographic findings in significant cardiac amyloidosis detected only at necropsy: comparison with cases diagnosed in life. Arq Bras Cardiol (2008) 0.90
I Brazilian guidelines on myocarditis and pericarditis. Arq Bras Cardiol (2013) 0.90
Myocardial fibrosis detected by cardiac CT predicts ventricular fibrillation/ventricular tachycardia events in patients with hypertrophic cardiomyopathy. J Cardiovasc Comput Tomogr (2013) 0.89
Association of mannose-binding lectin gene polymorphism but not of mannose-binding serine protease 2 with chronic severe aortic regurgitation of rheumatic etiology. Clin Vaccine Immunol (2008) 0.89
The effect of beta-blockade on myocardial remodelling in Chagas' cardiomyopathy. Clinics (Sao Paulo) (2012) 0.89
BAT1, a putative anti-inflammatory gene, is associated with chronic Chagas cardiomyopathy. J Infect Dis (2006) 0.88
[Heart failure with preserved systolic function]. Arq Bras Cardiol (2004) 0.88
Infective endocarditis due to Bartonella spp. and Coxiella burnetii: experience at a cardiology hospital in Sao Paulo, Brazil. Ann N Y Acad Sci (2006) 0.87
The monocyte chemoattractant protein-1 gene polymorphism is associated with cardiomyopathy in human chagas disease. Clin Infect Dis (2006) 0.87
Screening of MYH7, MYBPC3, and TNNT2 genes in Brazilian patients with hypertrophic cardiomyopathy. Am Heart J (2013) 0.87
Natural products to anti-trypanosomal drugs: an overview of new drug prototypes for American Trypanosomiasis. Cardiovasc Hematol Agents Med Chem (2007) 0.86
In patients with acute myocardial infarction, the impact of hyperglycemia as a risk factor for mortality is not homogeneous across age-groups. Diabetes Care (2011) 0.86
Bartonella spp. and Coxiella burnetii Associated with Community-Acquired, Culture-Negative Endocarditis, Brazil. Emerg Infect Dis (2015) 0.85
Genome wide association study (GWAS) of Chagas cardiomyopathy in Trypanosoma cruzi seropositive subjects. PLoS One (2013) 0.85
[Myocardial fibrosis in patients with hypertrophic cardiomyopathy and high risk for sudden death]. Arq Bras Cardiol (2010) 0.85
Coinfection with Mycoplasma pneumoniae and Chlamydia pneumoniae in ruptured plaques associated with acute myocardial infarction. Arq Bras Cardiol (2003) 0.85
Correlation of myocardial interstitial collagen in the right ventricular septum with ventricular function of patients with ischemic cardiomyopathy. Arq Bras Cardiol (2009) 0.85
Quantification of regional left and right ventricular deformation indices in healthy neonates by using strain rate and strain imaging. J Am Soc Echocardiogr (2009) 0.85
Polymorphisms in the gene for lymphotoxin-alpha predispose to chronic Chagas cardiomyopathy. J Infect Dis (2007) 0.85
Postoperative outcome of patients with prosthetic valve leak. Arq Bras Cardiol (2009) 0.84
Rheumatic heart disease: 15 years of clinical and immunological follow-up. Vasc Health Risk Manag (2007) 0.84
Lack of association of tumor necrosis factor-alpha polymorphisms with Chagas disease in Brazilian patients. Immunol Lett (2006) 0.84
Aneurysmal dilation of the reimplant segment of the visceral vessels after thoracoabdominal aneurysm correction. Arq Bras Cardiol (2003) 0.84
Variants in the promoter region of IKBL/NFKBIL1 gene may mark susceptibility to the development of chronic Chagas' cardiomyopathy among Trypanosoma cruzi-infected individuals. Mol Immunol (2007) 0.84
[Major clinical characteristics of patients surviving 24 months or more after hospitalization due to decompensated heart failure]. Arq Bras Cardiol (2005) 0.84
Relationship between outflow obstruction and left ventricular functional impairment in hypertrophic cardiomyopathy: a Doppler echocardiographic study. Echocardiography (2006) 0.83
Ten-year outcomes of patients randomized to surgery, angioplasty, or medical treatment for stable multivessel coronary disease: effect of age in the Medicine, Angioplasty, or Surgery Study II trial. J Thorac Cardiovasc Surg (2012) 0.83
Emergency service admission time and in-hospital mortality in acute coronary syndrome. Arq Bras Cardiol (2012) 0.83
Coronary flow reserve in sickle cell anemia. Arq Bras Cardiol (2007) 0.83
Benign outcome in a long-term follow-up of patients with hypertrophic cardiomyopathy in Brazil. Am Heart J (2005) 0.83
Quality of life after surgical myocardial revascularization, angioplasty or medical treatment. Arq Bras Cardiol (2007) 0.83
In-hospital death in acute coronary syndrome was related to admission glucose in men but not in women. Cardiovasc Diabetol (2012) 0.83
Effect of complete revascularization on 10-year survival of patients with stable multivessel coronary artery disease: MASS II trial. Circulation (2012) 0.83
Value of real time three-dimensional echocardiography in patients with hypertrophic cardiomyopathy: comparison with two-dimensional echocardiography and magnetic resonance imaging. Echocardiography (2008) 0.83
Study of pro-thrombotic and pro-inflammatory factors in Chagas cardiomyopathy. Arq Bras Cardiol (2010) 0.83
Sequential changes of longitudinal and radial myocardial deformation indices in the healthy neonate heart. J Am Soc Echocardiogr (2010) 0.83
Aldosterone antagonism in an inflammatory state: evidence for myocardial protection. J Renin Angiotensin Aldosterone Syst (2006) 0.83
Density of Chlamydia pneumoniae is increased in fibrotic and calcified areas of degenerative aortic stenosis. Int J Cardiol (2005) 0.83
Natriuretic peptides and long-term mortality in patients with severe aortic stenosis. J Heart Valve Dis (2012) 0.83
Aortic root reconstruction through valve-sparing operation: critical analysis of 11 years of follow-up. Rev Bras Cir Cardiovasc (2010) 0.83
Holt-Oram syndrome presenting as agenesis of the left pericardium. Int J Cardiol (2006) 0.82
Echocardiographic assessment of global ventricular function using the myocardial performance index in rats with hypertrophy. Artif Organs (2004) 0.82
Clinical meaning of ascites in patients with endomyocardial fibrosis. Arq Bras Cardiol (2002) 0.82
Analysis of aortic root surgery with composite mechanical aortic valve conduit and valve-sparing reconstruction. Rev Bras Cir Cardiovasc (2011) 0.82
Leptin in heart failure. Expert Opin Med Diagn (2012) 0.82
Effects of exercise training on myocardial blood flow reserve in patients with heart failure and left ventricular systolic dysfunction. Am J Cardiol (2009) 0.82
Effect of enalapril on left ventricular diameters and exercise capacity in asymptomatic or mildly symptomatic patients with regurgitation secondary to mitral valve prolapse or rheumatic heart disease. Am J Cardiol (2005) 0.82
Muscle sympathetic nerve activity in patients with Chagas' disease. Int J Cardiol (2008) 0.81
Warfarin or aspirin in embolism prevention in patients with mitral valvulopathy and atrial fibrillation. Arq Bras Cardiol (2010) 0.81